Mecwins is thrilled to announce that the Japan Patent Office has granted a new patent for an innovative method of digitally counting nanoparticles. The patent, entitled “Method for optically detecting biomarkers” (Patent JP7467205B2), represents a significant advancement in biosensor technology.
This patented method provides a cutting-edge solution for detecting biomarkers by acquiring and analyzing spatially and spectrally resolved images, correcting data to reduce noise, and using statistical values to classify and count particles. This is a cornerstone achievement to successfully achieve the digital counting of protein biomarkers.
The granting of this patent underscores Mecwins' commitment to innovation and excellence in the field of nanotechnology and biosensing. This achievement not only enhances our intellectual property portfolio but also strengthens our position as one of the most relevant actors in the innovation of technological solutions for the healthcare field.
We are proud to share the official patent certificate, marking this milestone in our journey towards technological excellence:
